ArticleCancer letters2024

Integration of transcriptomics, proteomics and loss-of-function screening reveals WEE1 as a target for combination with dasatinib against proneural glioblastoma.

Obada T Alhalabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.